Paracétamol Biogaran may be available in the countries listed below.
Ingredient matches for Paracétamol Biogaran
Paracetamol is reported as an ingredient of Paracétamol Biogaran in the following countries:
- France
International Drug Name Search
Paracétamol Biogaran may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paracétamol Biogaran in the following countries:
International Drug Name Search
troe-va-FLOX-a-sin
Available Dosage Forms:
Therapeutic Class: Antibiotic
Chemical Class: Fluoroquinolone
Alatrofloxacin and trovafloxacin are used to treat very serious bacterial infections in many different parts of the body. They work by killing bacteria or preventing their growth. However, these medicines will not work for colds, flu, or other virus infections.
Liver failure has been reported rarely with the use of alatrofloxacin and trovafloxacin. Because of the risk of liver problems, these medicines are used only to treat serious bacterial infections, such as those that are life-threatening or when there is a risk of losing a limb. Because of this, treatment usually is started in the hospital or in another inpatient health care facility.
These medicines were available only with your doctor's prescription.
The marketing and distribution of trovafloxacin (and alatrofloxacin) have been discontinued.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For trovafloxacin, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to trovafloxacin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Use is not recommended for infants, children, or teenagers up to 18 years of age since alatrofloxacin and trovafloxacin have been shown to cause bone development problems in young animals.
Alatrofloxacin and trovafloxacin have been tested in and, in effective doses, have not been shown to cause different side effects or problems in older people than they do in younger adults.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking trovafloxacin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using trovafloxacin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using trovafloxacin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of trovafloxacin. Make sure you tell your doctor if you have any other medical problems, especially:
Do not take alatrofloxacin or trovafloxacin if you are pregnant. Do not give alatrofloxacin or trovafloxacin to infants, children, or teenagers unless otherwise specified by your doctor. These medicines have been shown to cause bone development problems in young animals.
Trovafloxacin tablets may be taken with or without meals.
If you are taking alatrofloxacin injection, use it exactly as directed by your doctor. If you have any questions, ask your health care professional.
To help clear up your infection completely, keep taking alatrofloxacin or trovafloxacin for the full time of treatment, even if you begin to feel better after a few days. If you stop taking trovafloxacin too soon, your symptoms may return.
Alatrofloxacin and trovafloxacin work best when there is a constant amount in the blood or urine. To help keep the amount constant, do not miss any doses. Also, it is best to take the doses at evenly spaced times, day and night. For example, if you are to take one dose a day, that dose should be taken about the same time every day. If this interferes with your sleep or other daily activities, or if you need help in planning the best time to take your medicine, check with your health care professional.
The dose of trovafloxacin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of trovafloxacin. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of trovafloxacin, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Alatrofloxacin and trovafloxacin may cause liver problems, including liver failure, at any time during treatment in a small number of people who are treated with these medicines. Check with your doctor immediately if you notice that your urine has become dark or your skin or eyes are yellow in color or if you experience loss of appetite, nausea or vomiting, severe abdominal pain, or unusual tiredness or weakness. These may be possible signs or symptoms of a liver problem.
If you are taking aluminum- or magnesium-containing antacids, citric acid buffered with sodium citrate (e.g., Bicitra), iron supplements or vitamins, intravenous morphine, or sucralfate, do not take them at the same time that you take trovafloxacin tablets. It is best to take these medicines at least 2 hours before or 2 hours after taking trovafloxacin. These medicines may keep trovafloxacin tablets from working properly.
Some people who take alatrofloxacin or trovafloxacin may become more sensitive to sunlight than they are normally. Exposure to sunlight, even for brief periods of time, may cause severe sunburn or skin rash, redness, itching, or discoloration. When you begin taking trovafloxacin:
If you have a severe reaction from the sun, check with your doctor.
Alatrofloxacin or trovafloxacin may cause some people to become dizzy, lightheaded, or less alert than they are normally. Make sure you know how you react to trovafloxacin before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert. If these reactions are especially bothersome, check with your doctor.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Note: Some of the above side effects may also occur up to several weeks after you stop taking trovafloxacin.
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: trovafloxacin side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Ascatene may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Niclosamide is reported as an ingredient of Ascatene in the following countries:
Pyrantel tartrate (a derivative of Pyrantel) is reported as an ingredient of Ascatene in the following countries:
International Drug Name Search
Rothacin may be available in the countries listed below.
Indometacin is reported as an ingredient of Rothacin in the following countries:
International Drug Name Search
Brodilan may be available in the countries listed below.
Clenbuterol hydrochloride (a derivative of Clenbuterol) is reported as an ingredient of Brodilan in the following countries:
International Drug Name Search
Gadavist is a brand name of gadobutrol, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Gadavist available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gadavist. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Azithromycin Hexal may be available in the countries listed below.
Azithromycin is reported as an ingredient of Azithromycin Hexal in the following countries:
Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Azithromycin Hexal in the following countries:
Azithromycin monohydrate (a derivative of Azithromycin) is reported as an ingredient of Azithromycin Hexal in the following countries:
International Drug Name Search